Sequential alterations in the human eosinophil content of arylsulfatase B during therapy of Bancroftian filariasis.
D002803:Chondro-4-Sulfatase / Q000378:metabolism*; D004049:Diethylcarbamazine / Q000627:therapeutic use; D004804:Eosinophils / Q000201:enzymology*; D005368:Filariasis / Q000188:drug therapy*; D005966:Glucuronidase / Q000378:metabolism; D006098:Granulocytes / Q000201:enzymology; D006801:Humans; D007958:Leukocyte Count; D010544:Peroxidases / Q000378:metabolism; D013429:Sulfatases / Q000378:metabolism*; D013997:Time Factors; D014958:Wuchereria bancrofti
D010544:Peroxidases; D013429:Sulfatases; D002803:Chondro-4-Sulfatase; D005966:Glucuronidase; D004049:Diethylcarbamazine